Literature DB >> 33531668

Disrupted intraflagellar transport due to IFT74 variants causes Joubert syndrome.

Minna Luo1, Zaisheng Lin2, Tian Zhu3, Minjun Jin4, Dan Meng5, Ruida He2, Zongfu Cao1, Yue Shen1, Chao Lu1, Ruikun Cai1, Yong Zhao6, Xueyan Wang7, Hui Li3, Shijing Wu3, Xuan Zou3, Guanjun Luo6, Li Cao8, Min Huang2, Huike Jiao2, Huafang Gao1, Ruifang Sui9, Chengtian Zhao10, Xu Ma11, Muqing Cao12.   

Abstract

PURPOSE: Ciliopathies are a group of disorders caused by defects of the cilia. Joubert syndrome (JBTS) is a recessive and pleiotropic ciliopathy that causes cerebellar vermis hypoplasia and psychomotor delay. Although the intraflagellar transport (IFT) complex serves as a key module to maintain the ciliary structure and regulate ciliary signaling, the function of IFT in JBTS remains largely unknown. We aimed to explore the impact of IFT dysfunction in JBTS.
METHODS: Exome sequencing was performed to screen for pathogenic variants in IFT genes in a JBTS cohort. Animal model and patient-derived fibroblasts were used to evaluate the pathogenic effects of the variants.
RESULTS: We identified IFT74 as a JBTS-associated gene in three unrelated families. All the affected individuals carried truncated variants and shared one missense variant (p.Q179E) found only in East Asians. The expression of the human p.Q179E-IFT74 variant displayed compromised rescue effects in zebrafish ift74 morphants. Attenuated ciliogenesis; altered distribution of IFT proteins and ciliary membrane proteins, including ARL13B, INPP5E, and GPR161; and disrupted hedgehog signaling were observed in patient fibroblasts with IFT74 variants.
CONCLUSION: IFT74 is identified as a JBTS-related gene. Cellular and biochemical mechanisms are also provided.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33531668     DOI: 10.1038/s41436-021-01106-z

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  1 in total

1.  Regulation of ciliary retrograde protein trafficking by the Joubert syndrome proteins ARL13B and INPP5E.

Authors:  Shohei Nozaki; Yohei Katoh; Masaya Terada; Saki Michisaka; Teruki Funabashi; Senye Takahashi; Kenji Kontani; Kazuhisa Nakayama
Journal:  J Cell Sci       Date:  2016-12-07       Impact factor: 5.285

  1 in total
  5 in total

Review 1.  The Joubert-Meckel-Nephronophthisis Spectrum of Ciliopathies.

Authors:  Julie C Van De Weghe; Arianna Gomez; Dan Doherty
Journal:  Annu Rev Genomics Hum Genet       Date:  2022-06-02       Impact factor: 9.340

2.  Spatial and cell type transcriptional landscape of human cerebellar development.

Authors:  Kimberly A Aldinger; Zachary Thomson; Ian G Phelps; Parthiv Haldipur; Mei Deng; Andrew E Timms; Matthew Hirano; Gabriel Santpere; Charles Roco; Alexander B Rosenberg; Belen Lorente-Galdos; Forrest O Gulden; Diana O'Day; Lynne M Overman; Steven N Lisgo; Paula Alexandre; Nenad Sestan; Dan Doherty; William B Dobyns; Georg Seelig; Ian A Glass; Kathleen J Millen
Journal:  Nat Neurosci       Date:  2021-06-17       Impact factor: 28.771

3.  Case Report: Preimplantation Genetic Testing for Meckel Syndrome Induced by Novel Compound Heterozygous Mutations of MKS1.

Authors:  Tingting Lin; Yongyi Ma; Danni Zhou; Liwei Sun; Ke Chen; Yezhou Xiang; Keya Tong; Chaoli Jia; Kean Jiang; Dongyun Liu; Guoning Huang
Journal:  Front Genet       Date:  2022-03-14       Impact factor: 4.599

Review 4.  Genotype-phenotype correlates in Joubert syndrome: A review.

Authors:  Simone Gana; Valentina Serpieri; Enza Maria Valente
Journal:  Am J Med Genet C Semin Med Genet       Date:  2022-03-03       Impact factor: 3.359

Review 5.  Genetics behind Cerebral Disease with Ocular Comorbidity: Finding Parallels between the Brain and Eye Molecular Pathology.

Authors:  Kao-Jung Chang; Hsin-Yu Wu; Aliaksandr A Yarmishyn; Cheng-Yi Li; Yu-Jer Hsiao; Yi-Chun Chi; Tzu-Chen Lo; He-Jhen Dai; Yi-Chiang Yang; Ding-Hao Liu; De-Kuang Hwang; Shih-Jen Chen; Chih-Chien Hsu; Chung-Lan Kao
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.